Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

ESMO and Thomson Reuters collaborate on oncology web portal

Oct. 14, 2010

ArQule and Daiichi Sankyo expand new kinase inhibitor discovery collaboration

Oct. 14, 2010

Genmab and Lundbeck to collaborate on human antibodies for CNS disorders

Oct. 14, 2010

Lundbeck acquires exclusive commercial rights to Sycrest outside U.S., China and Japan

Oct. 13, 2010

Novartis to use ImmunoGen's TAP technology to develop anticancer therapeutics

Oct. 13, 2010

Exelixis and Bristol-Myers Squibb collaborate on multiple small-molecule programs

Oct. 13, 2010

Amylin Pharma to use Affibody's Albumod platform under new license agreement

Oct. 11, 2010

Roche buys rights to hepatitis C therapy danoprevir from InterMune

Oct. 8, 2010

NCI and Lixte Biotechnology collaborate on anticancer agent LB-100

Oct. 8, 2010

Starpharma and Lilly collaborate on dendrimer-drug conjugate development

Oct. 7, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...